TY - JOUR
T1 - Early cytotoxic effects of ochratoxin A in rat liver
T2 - A morphological, biochemical and molecular study
AU - Gagliano, Nicoletta
AU - Donne, Isabella Dalle
AU - Torri, Carlo
AU - Migliori, Massimiliano
AU - Grizzi, Fabio
AU - Milzani, Aldo
AU - Filippi, Cristina
AU - Annoni, Giorgio
AU - Colombo, Piergiuseppe
AU - Costa, Francesco
AU - Ceva-Grimaldi, Giorgia
AU - Bertelli, Alberto A E
AU - Giovannini, Luca
AU - Gioia, Magda
PY - 2006/8/15
Y1 - 2006/8/15
N2 - We characterized the overall early effect of chronic ochratoxin A (OTA) treatment on rat liver, analyzing different aspects related to: (i) fibrosis, by measuring collagen content and turnover, and α-smooth muscle actin (αSMA); (ii) oxidative stress and stress response, by analyzing protein carbonylation, superoxide dismutase (SOD) and heat shock protein (HSP70) gene expression; (iii) the possible tumor promoter effect, evaluating cadherin and connexin (CX) mRNA levels. Light microscopy analysis showed no histological differences in OTA-treated and control (CT) rats. Collagen content, determined by computer analysis of Sirius red-stained liver sections, was similar in both groups. In liver homogenates COL-I, COL-III, TIMP-1 and TGF-β1 mRNA levels and αSMA were unaffected by OTA. Matrix metalloproteinase (MMP)-1, MMP-2 and MMP-9 protein levels were also similar in the two groups. Protein carbonylation, a marker of severe oxidative stress, was not evident in the homogenates of OTA-treated livers; superoxide dismutase (SOD) mRNA tended to be lower and HSP70 was strongly down-regulated. OTA reduced E-cadherin and DSC-2 transcription, and down-regulated liver CX26, CX32 and CX43. In conclusion, these in vivo results show that OTA-induced liver injury involves a reduction in the ability to counterbalance oxidative stress, maybe leading to altered gap junction intercellular communication and loss of cell adhesion and polarity. This suggests that mild oxidative damage might be a key factor, in combination with other cytotoxic effects, in triggering the promotion of liver tumors after exposure to OTA.
AB - We characterized the overall early effect of chronic ochratoxin A (OTA) treatment on rat liver, analyzing different aspects related to: (i) fibrosis, by measuring collagen content and turnover, and α-smooth muscle actin (αSMA); (ii) oxidative stress and stress response, by analyzing protein carbonylation, superoxide dismutase (SOD) and heat shock protein (HSP70) gene expression; (iii) the possible tumor promoter effect, evaluating cadherin and connexin (CX) mRNA levels. Light microscopy analysis showed no histological differences in OTA-treated and control (CT) rats. Collagen content, determined by computer analysis of Sirius red-stained liver sections, was similar in both groups. In liver homogenates COL-I, COL-III, TIMP-1 and TGF-β1 mRNA levels and αSMA were unaffected by OTA. Matrix metalloproteinase (MMP)-1, MMP-2 and MMP-9 protein levels were also similar in the two groups. Protein carbonylation, a marker of severe oxidative stress, was not evident in the homogenates of OTA-treated livers; superoxide dismutase (SOD) mRNA tended to be lower and HSP70 was strongly down-regulated. OTA reduced E-cadherin and DSC-2 transcription, and down-regulated liver CX26, CX32 and CX43. In conclusion, these in vivo results show that OTA-induced liver injury involves a reduction in the ability to counterbalance oxidative stress, maybe leading to altered gap junction intercellular communication and loss of cell adhesion and polarity. This suggests that mild oxidative damage might be a key factor, in combination with other cytotoxic effects, in triggering the promotion of liver tumors after exposure to OTA.
KW - Cadherins
KW - Collagen turnover
KW - Connexins
KW - HSP70
KW - Ochratoxin A
KW - Oxidative stress
UR - http://www.scopus.com/inward/record.url?scp=33746832056&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33746832056&partnerID=8YFLogxK
U2 - 10.1016/j.tox.2006.06.004
DO - 10.1016/j.tox.2006.06.004
M3 - Article
C2 - 16857307
AN - SCOPUS:33746832056
SN - 0300-483X
VL - 225
SP - 214
EP - 224
JO - Toxicology
JF - Toxicology
IS - 2-3
ER -